Testing effectiveness (Phase 2)Study completedNCT03299686
What this trial is testing
Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma
Who this might be right for
Asthma
Novartis Pharmaceuticals 118